Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Carolina Schinke

Concepts (322)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Myeloma
80
2025
2999
9.290
Why?
Antibodies, Bispecific
10
2025
88
3.750
Why?
B-Cell Maturation Antigen
9
2025
92
2.440
Why?
Hematopoietic Stem Cell Transplantation
8
2024
597
1.890
Why?
Bone Marrow
11
2024
361
1.300
Why?
Monoclonal Gammopathy of Undetermined Significance
5
2025
120
1.290
Why?
Neoplasm, Residual
7
2025
170
1.290
Why?
Leukemia, Plasma Cell
2
2020
33
1.260
Why?
Humans
95
2025
52114
1.260
Why?
Neoplasms, Plasma Cell
3
2024
35
1.230
Why?
Paraproteinemias
2
2022
72
1.220
Why?
Positron-Emission Tomography
5
2025
297
1.160
Why?
Immunotherapy, Adoptive
6
2024
155
1.120
Why?
Neoplasm Recurrence, Local
8
2025
630
1.050
Why?
Diffusion Magnetic Resonance Imaging
3
2025
132
1.050
Why?
Aged
29
2025
10142
0.990
Why?
Immunoglobulin Light Chains
2
2017
90
0.960
Why?
Prognosis
18
2025
2093
0.920
Why?
Transplantation, Autologous
9
2024
480
0.910
Why?
Gene Expression Regulation, Neoplastic
10
2024
853
0.880
Why?
Immunoglobulins, Intravenous
1
2025
63
0.880
Why?
Myelodysplastic Syndromes
5
2016
85
0.850
Why?
Immunoconjugates
2
2022
36
0.840
Why?
Mutation
8
2022
1318
0.830
Why?
Middle Aged
28
2025
13028
0.830
Why?
Antibodies, Monoclonal
6
2023
475
0.770
Why?
Male
36
2025
26652
0.750
Why?
Leukemia, Myeloid, Acute
4
2019
201
0.740
Why?
Gene Expression Profiling
11
2025
1101
0.730
Why?
Adult
24
2025
14095
0.720
Why?
Health Personnel
1
2024
251
0.720
Why?
Testis
1
2021
72
0.670
Why?
Signal Transduction
6
2024
1699
0.660
Why?
Aged, 80 and over
12
2025
3382
0.650
Why?
Tumor Microenvironment
5
2024
246
0.650
Why?
Hematopoietic Stem Cells
3
2019
188
0.630
Why?
Plasma Cells
6
2025
234
0.620
Why?
Quality of Life
1
2025
878
0.620
Why?
Cell Proliferation
8
2023
1017
0.610
Why?
Female
32
2025
28055
0.610
Why?
Clonal Evolution
4
2024
59
0.600
Why?
Gene Expression
3
2018
618
0.590
Why?
Clinical Trials as Topic
6
2023
463
0.540
Why?
Antineoplastic Combined Chemotherapy Protocols
5
2024
1020
0.540
Why?
Translocation, Genetic
5
2021
265
0.520
Why?
Thoracic Neoplasms
1
2016
13
0.490
Why?
Plasmacytoma
1
2016
43
0.480
Why?
Receptors, Interleukin-8B
1
2015
5
0.460
Why?
Survival Analysis
8
2024
667
0.460
Why?
Interleukin-8
1
2015
86
0.450
Why?
Receptors, G-Protein-Coupled
2
2024
54
0.420
Why?
Antineoplastic Agents
7
2024
1214
0.400
Why?
Combined Modality Therapy
4
2024
634
0.390
Why?
Fluorodeoxyglucose F18
5
2021
181
0.380
Why?
Neutropenia
2
2023
113
0.370
Why?
DNA Methylation
4
2020
583
0.370
Why?
Neoplasms, Second Primary
2
2024
75
0.360
Why?
Oncogene Proteins, Fusion
2
2018
60
0.360
Why?
Chromosomes, Human, Pair 1
3
2023
95
0.350
Why?
Polycomb Repressive Complex 2
2
2021
48
0.350
Why?
Stem Cell Transplantation
3
2022
186
0.340
Why?
Epigenesis, Genetic
4
2020
401
0.340
Why?
Evolution, Molecular
2
2021
95
0.340
Why?
Tretinoin
1
2010
53
0.320
Why?
Treatment Outcome
10
2025
5456
0.310
Why?
Cell Line, Tumor
7
2024
1418
0.310
Why?
Risk Assessment
4
2024
1339
0.300
Why?
Transcription Factors
3
2023
564
0.300
Why?
Transcriptome
3
2025
363
0.300
Why?
Immunoglobulin kappa-Chains
2
2021
22
0.300
Why?
Disease Progression
8
2025
866
0.290
Why?
DNA-Binding Proteins
2
2021
424
0.280
Why?
Neoplasm Proteins
3
2020
328
0.270
Why?
Melanoma
1
2010
278
0.260
Why?
RANK Ligand
2
2024
187
0.250
Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
2024
90
0.240
Why?
Biopsy
2
2018
599
0.240
Why?
Radiopharmaceuticals
3
2021
199
0.230
Why?
Skin Neoplasms
1
2010
499
0.230
Why?
Chemokine CCL3
1
2024
12
0.220
Why?
Retrospective Studies
7
2025
6610
0.220
Why?
HMGB1 Protein
1
2024
21
0.220
Why?
Dexamethasone
3
2024
435
0.220
Why?
T-Lymphocytes
5
2024
316
0.220
Why?
Kaplan-Meier Estimate
3
2021
482
0.220
Why?
Sialic Acid Binding Ig-like Lectin 2
1
2024
2
0.220
Why?
Chemokine CXCL12
1
2024
34
0.220
Why?
Antigens, CD19
1
2024
28
0.210
Why?
Mutation Rate
2
2021
36
0.210
Why?
Bone Resorption
2
2024
302
0.210
Why?
Recurrence
6
2025
680
0.210
Why?
Genome-Wide Association Study
1
2024
184
0.200
Why?
Myeloproliferative Disorders
1
2023
31
0.200
Why?
Cell Cycle
2
2021
237
0.200
Why?
Neoplasm Staging
2
2024
766
0.200
Why?
Genomics
2
2023
265
0.190
Why?
Proto-Oncogene Proteins B-raf
2
2020
77
0.190
Why?
Drug Approval
1
2022
38
0.190
Why?
Qualitative Research
1
2024
358
0.190
Why?
Drug Resistance, Neoplasm
1
2024
324
0.190
Why?
Osteolysis
1
2022
74
0.180
Why?
Waldenstrom Macroglobulinemia
1
2022
38
0.180
Why?
Osteocytes
1
2024
225
0.180
Why?
Lymphoma, B-Cell
1
2022
61
0.180
Why?
Polymorphism, Single Nucleotide
1
2024
504
0.180
Why?
Bone Marrow Transplantation
1
2022
110
0.180
Why?
Hematologic Diseases
1
2021
21
0.180
Why?
Epigenomics
1
2021
74
0.180
Why?
Patient Participation
1
2022
68
0.180
Why?
Genetic Predisposition to Disease
1
2024
528
0.180
Why?
Mice
6
2024
5877
0.180
Why?
Chromosome Deletion
2
2023
139
0.170
Why?
Abnormal Karyotype
1
2021
6
0.170
Why?
Drug Design
2
2013
121
0.170
Why?
Myeloma Proteins
1
2021
26
0.170
Why?
Risk Factors
8
2024
3922
0.170
Why?
Immunoglobulin A
1
2021
46
0.170
Why?
Communicable Diseases
1
2021
55
0.170
Why?
Antibodies, Monoclonal, Humanized
1
2022
232
0.170
Why?
Hematologic Neoplasms
1
2022
100
0.170
Why?
Genes, Tumor Suppressor
2
2021
73
0.170
Why?
Gene Expression Regulation, Leukemic
1
2020
32
0.170
Why?
Salvage Therapy
1
2021
136
0.160
Why?
Practice Guidelines as Topic
1
2023
494
0.160
Why?
Immunoglobulin G
1
2021
195
0.160
Why?
Exosome Multienzyme Ribonuclease Complex
1
2020
12
0.160
Why?
Bone Diseases
1
2021
92
0.160
Why?
Neoplasm Invasiveness
1
2021
277
0.160
Why?
Gene Amplification
1
2019
58
0.160
Why?
Chromosomal Instability
1
2019
16
0.160
Why?
Gene Regulatory Networks
1
2020
111
0.160
Why?
Hematopoiesis, Extramedullary
1
2019
9
0.160
Why?
Atrial Fibrillation
1
2022
200
0.150
Why?
United States
3
2024
5168
0.150
Why?
Insulin-Like Growth Factor Binding Protein 2
1
2018
10
0.150
Why?
Healthcare Disparities
1
2022
296
0.150
Why?
Comorbidity
1
2021
628
0.150
Why?
Models, Statistical
1
2020
231
0.150
Why?
Sulfonamides
1
2019
132
0.150
Why?
Animals
8
2024
13332
0.150
Why?
Spleen
1
2019
169
0.140
Why?
Spinal Fractures
1
2018
38
0.140
Why?
Phosphotransferases
1
2018
17
0.140
Why?
Bacteremia
1
2019
89
0.140
Why?
Adipocytes
1
2018
130
0.140
Why?
Cell Differentiation
3
2022
670
0.140
Why?
Gene Rearrangement
1
2018
76
0.130
Why?
Disease-Free Survival
4
2019
462
0.130
Why?
Kidney Function Tests
1
2017
55
0.130
Why?
Hexokinase
1
2017
16
0.130
Why?
Chromosomes, Human, Pair 17
1
2017
35
0.130
Why?
Calcification, Physiologic
1
2017
42
0.130
Why?
Glomerular Filtration Rate
1
2017
127
0.130
Why?
Survival Rate
4
2020
945
0.130
Why?
Chromosome Aberrations
2
2023
295
0.130
Why?
Pelvis
1
2017
66
0.130
Why?
Histoplasma
1
2016
24
0.130
Why?
HIV Infections
1
2021
382
0.130
Why?
CA-125 Antigen
1
2016
16
0.130
Why?
Receptor, TIE-2
1
2016
16
0.130
Why?
Cardiomyopathy, Restrictive
1
2016
5
0.120
Why?
Histoplasmosis
1
2016
47
0.120
Why?
Urea
1
2016
79
0.120
Why?
Indazoles
1
2016
47
0.120
Why?
p38 Mitogen-Activated Protein Kinases
1
2016
94
0.120
Why?
Gene Expression Regulation, Enzymologic
1
2017
181
0.120
Why?
Remission Induction
3
2024
218
0.120
Why?
Gastrointestinal Diseases
1
2016
126
0.120
Why?
Tumor Suppressor Protein p53
1
2017
224
0.120
Why?
Proteasome Inhibitors
1
2016
101
0.110
Why?
Immunologic Factors
1
2016
117
0.110
Why?
Cell Cycle Checkpoints
1
2015
32
0.110
Why?
Time Factors
2
2021
2970
0.110
Why?
Kidney Diseases
1
2017
229
0.110
Why?
Cluster Analysis
1
2015
236
0.110
Why?
Xenograft Model Antitumor Assays
1
2015
216
0.110
Why?
Thrombopoiesis
1
2014
5
0.110
Why?
Neoplastic Stem Cells
1
2015
90
0.110
Why?
Hydrazines
1
2014
18
0.110
Why?
Myocardium
1
2017
477
0.110
Why?
Benzoates
1
2014
21
0.110
Why?
Immunotherapy
1
2016
240
0.110
Why?
Cystatin M
2
2024
17
0.100
Why?
Disease Models, Animal
2
2016
1467
0.100
Why?
Cell Survival
1
2015
596
0.100
Why?
Cross-Sectional Studies
3
2023
1665
0.100
Why?
Pyrazoles
1
2014
113
0.100
Why?
Chromosomes, Human, Pair 7
1
2012
29
0.100
Why?
Clone Cells
2
2023
76
0.090
Why?
Flow Cytometry
2
2012
397
0.090
Why?
Cardiovascular Diseases
1
2017
493
0.090
Why?
STAT3 Transcription Factor
1
2012
86
0.090
Why?
Chromatin
2
2024
141
0.090
Why?
Cell Transformation, Neoplastic
1
2013
184
0.090
Why?
Thalidomide
1
2014
377
0.090
Why?
Follow-Up Studies
3
2024
2282
0.090
Why?
In Situ Hybridization, Fluorescence
2
2023
262
0.080
Why?
Leukemia, Promyelocytic, Acute
1
2010
11
0.080
Why?
Luciferases
1
2010
50
0.080
Why?
Response Elements
1
2010
29
0.080
Why?
Gene Silencing
1
2010
120
0.080
Why?
Alleles
2
2021
277
0.080
Why?
Tumor Burden
2
2020
133
0.080
Why?
Recombinant Fusion Proteins
1
2010
173
0.080
Why?
Transfection
1
2010
366
0.080
Why?
Molecular Structure
1
2010
315
0.080
Why?
Histones
2
2021
316
0.070
Why?
Apoptosis
2
2014
1117
0.070
Why?
DNA Copy Number Variations
2
2021
117
0.070
Why?
Syndecan-1
2
2021
73
0.070
Why?
Case-Control Studies
2
2024
1193
0.060
Why?
Tumor Cells, Cultured
2
2020
445
0.060
Why?
Imaging, Three-Dimensional
2
2017
147
0.060
Why?
Gene Expression Regulation
1
2010
1000
0.060
Why?
Transmembrane Activator and CAML Interactor Protein
1
2024
6
0.060
Why?
Mendelian Randomization Analysis
1
2024
7
0.060
Why?
ROC Curve
1
2025
250
0.060
Why?
Arkansas
2
2021
2016
0.050
Why?
Telomere
1
2024
39
0.050
Why?
Mitogen-Activated Protein Kinase Kinases
1
2024
34
0.050
Why?
Ferritins
1
2024
36
0.050
Why?
Killer Cells, Natural
1
2024
112
0.050
Why?
Myeloid Progenitor Cells
1
2023
15
0.050
Why?
CD8-Positive T-Lymphocytes
1
2024
128
0.050
Why?
X-Ray Microtomography
1
2024
77
0.050
Why?
Antibodies
1
2024
148
0.050
Why?
Receptors, Antigen, T-Cell
1
2023
46
0.050
Why?
B-Lymphocytes
1
2024
180
0.050
Why?
Demography
1
2023
92
0.050
Why?
Cell Communication
1
2023
72
0.050
Why?
Neoplasms
1
2013
1288
0.050
Why?
TNF Receptor-Associated Factor 3
1
2022
13
0.050
Why?
Patients
1
2022
50
0.050
Why?
Geography
1
2022
65
0.050
Why?
Myeloid Differentiation Factor 88
1
2022
32
0.050
Why?
United States Food and Drug Administration
1
2022
90
0.050
Why?
Patient Selection
1
2023
265
0.050
Why?
Infant
1
2010
3660
0.050
Why?
Oncogenes
1
2021
60
0.050
Why?
Tomography, X-Ray Computed
2
2017
1148
0.040
Why?
Phylogeny
1
2022
229
0.040
Why?
SOXC Transcription Factors
1
2021
13
0.040
Why?
Transcriptional Activation
1
2021
128
0.040
Why?
Lymphoma, Large B-Cell, Diffuse
1
2022
105
0.040
Why?
Pyrimidines
1
2022
198
0.040
Why?
Proto-Oncogene Proteins p21(ras)
1
2021
68
0.040
Why?
Cyclin D2
1
2020
21
0.040
Why?
Aneuploidy
1
2020
18
0.040
Why?
Proto-Oncogene Proteins c-maf
1
2020
19
0.040
Why?
Chromosomes, Human, Pair 4
1
2020
30
0.040
Why?
ras Proteins
1
2020
63
0.040
Why?
Histone Code
1
2020
32
0.040
Why?
Cyclin D1
1
2020
57
0.040
Why?
Chromosomes, Human, Pair 11
1
2020
55
0.040
Why?
Genome, Human
1
2021
121
0.040
Why?
Chromosomes, Human, Pair 14
1
2020
75
0.040
Why?
Protein Kinase Inhibitors
1
2022
225
0.040
Why?
DNA, Neoplasm
1
2020
146
0.040
Why?
DNA Mutational Analysis
1
2020
179
0.040
Why?
Osteoclasts
1
2022
427
0.040
Why?
Genetic Variation
1
2020
224
0.040
Why?
Health Status Disparities
1
2022
216
0.040
Why?
High-Throughput Nucleotide Sequencing
1
2020
174
0.040
Why?
Multivariate Analysis
1
2021
600
0.040
Why?
Computational Biology
1
2020
209
0.040
Why?
Gram-Positive Bacterial Infections
1
2019
30
0.040
Why?
Syndrome
1
2019
247
0.040
Why?
Pseudomonas Infections
1
2019
54
0.040
Why?
Fractures, Compression
1
2018
17
0.040
Why?
Randomized Controlled Trials as Topic
1
2021
608
0.040
Why?
Promoter Regions, Genetic
1
2020
465
0.040
Why?
Receptor Protein-Tyrosine Kinases
1
2018
52
0.030
Why?
Protein-Tyrosine Kinases
1
2018
87
0.030
Why?
False Positive Reactions
1
2017
63
0.030
Why?
Bone and Bones
1
2021
492
0.030
Why?
Amino Acid Sequence
1
2018
566
0.030
Why?
Itraconazole
1
2016
38
0.030
Why?
Alkaline Phosphatase
1
2017
92
0.030
Why?
beta-Glucans
1
2016
23
0.030
Why?
Databases, Factual
1
2020
714
0.030
Why?
Genes, ras
1
2016
43
0.030
Why?
Angiopoietin-1
1
2016
16
0.030
Why?
Amphotericin B
1
2016
104
0.030
Why?
Genes, p53
1
2016
52
0.030
Why?
Ileum
1
2016
88
0.030
Why?
Intestinal Obstruction
1
2016
38
0.030
Why?
NF-kappa B
1
2018
329
0.030
Why?
Glycolysis
1
2016
72
0.030
Why?
Gene Knockdown Techniques
1
2016
108
0.030
Why?
Colonoscopy
1
2016
107
0.030
Why?
Staphylococcal Infections
1
2019
272
0.030
Why?
Models, Genetic
1
2016
173
0.030
Why?
Genomic Instability
1
2016
89
0.030
Why?
Fever
1
2016
111
0.030
Why?
Drug Screening Assays, Antitumor
1
2016
136
0.030
Why?
Image Interpretation, Computer-Assisted
1
2016
96
0.030
Why?
Logistic Models
1
2018
925
0.030
Why?
Phosphatidylinositol 3-Kinases
1
2016
149
0.030
Why?
Heart
1
2017
360
0.030
Why?
Proportional Hazards Models
1
2016
439
0.030
Why?
Algorithms
1
2018
663
0.030
Why?
Echocardiography
1
2017
415
0.030
Why?
Weight Loss
1
2016
256
0.030
Why?
Megakaryocyte Progenitor Cells
1
2014
1
0.030
Why?
Young Adult
1
2024
4307
0.030
Why?
Antifungal Agents
1
2016
346
0.030
Why?
Longitudinal Studies
1
2016
742
0.030
Why?
Models, Immunological
1
2013
8
0.030
Why?
Chemistry, Pharmaceutical
1
2013
35
0.020
Why?
Early Diagnosis
1
2013
84
0.020
Why?
Karyotyping
1
2012
78
0.020
Why?
Azacitidine
1
2012
39
0.020
Why?
Primary Cell Culture
1
2012
62
0.020
Why?
Cell Lineage
1
2012
87
0.020
Why?
Polymerase Chain Reaction
1
2013
460
0.020
Why?
Child
1
2024
7147
0.020
Why?
Enzyme Inhibitors
1
2013
371
0.020
Why?
Antigens, CD
1
2012
215
0.020
Why?
Magnetic Resonance Imaging
1
2017
1518
0.020
Why?
Cytokines
1
2013
621
0.020
Why?
Reproducibility of Results
1
2013
1214
0.020
Why?
Cohort Studies
1
2013
1541
0.020
Why?
Schinke's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description